Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02449889Phase 3Completed
A Phase 3 trial of human chorionic gonadotropin in infertility, sponsored by Ferring Pharmaceuticals. Started Apr 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02449889.